Thirteen (13) PhD Positions, European Network Linking Informatics and Genomics of Helper T cells, Europe (2015-2016)

ENLIGHT-TEN is a Marie Sklodowska-Curie Innovative Training Network (ITN-ETN) funded in the framework of the HORIZON 2020 program. The mission of ENLIGHT-TEN is to provide cross-disciplinary training in T cell immunology and big data analysis in order to train a new generation of researchers to exploit the power of emerging technological platforms.

ENLIGHT-TEN has developed a cross-disciplinary, high-quality educational programme to provide all its PhD candidates with specialist high-level research training, a broad scientific skill set and experience in both academic and industrial working environments. In addition to excellent research skills, our training programme will also offer training in team-leading abilities, project management and entrepreneurship to supplement and complement the university-based PhD education.

ENLIGHT-TEN consists of ten beneficiaries and six partners from seven European countries, bringing a balanced portfolio of expertise bridging in-depth knowledge of T cell differentiation and pathophysiology of autoimmune and allergic diseases, through to bioinformatic analysis of large data sets. This strong network of academic and industrial partners ensures that ENLIGHT-TEN's early stage researchers will be extremely well placed to successfully compete for academic or industrial life science-related positions, and to drive research and innovation within the European Research Area.

Helmholtz Centre for Infection Research (Braunschweig/Hannover, Germany)
• ESR1: Functional importance and molecular characterisation of differentially methylated regions in helper T cell subsets
(Laboratory of Jochen Huehn)
• ESR2: Defining the role of metabolic pathways in helper T cell subsets
(Laboratory of Tim Sparwasser)

University College London (UK)
• ESR3: Follicular helper T cell differentiation in autoimmune diabetes: role of the CD28 pathway
(Laboratory of Lucy Walker)

Medical University of Vienna (Austria)
• ESR4: Transcriptional networks regulating helper and cytotoxic T cell lineage specification (Laboratory of Wilfried Ellmeier)

Qiagen Aarhus (Denmark)
• ESR5:Cross-omics prediction tools for analysis of gene regulatory sites in helper T cells
(Laboratory of Leif Schauser)

Bayer Pharma (Wuppertal, Germany)
• ESR6: Comparative model-based analysis of the translatability from in vitro to in vivo and from animal model to human of cytokine responses and adverse events of T cell engaging antibodies
(Laboratory of Jörg Lippert)

EMBL – EBI (Cambridge, UK)
• ESR7: Tracking helper T cell differentiation pathways one cell at a time
(Laboratory of Sarah Teichmann)

Instituto de Medicina Molecular (Lisbon, Portugal)
• ESR8: Factors determining thymic regulatory T cell development and peripheral homeostasis of naive regulatory T cells in humans
(Laboratory of Ana Sousa)
• ESR9: Functional subsets of human helper T cells
(Laboratory of Luis Graca)

Babraham Institute (Cambridge, UK)
• ESR10: How the T cell response upon vaccination changes with age
(Laboratory of Michelle Linterman)
• ESR11: Plasticity and reprogramming of differentiated T cells
(Laboratory of Marc Veldhoen)

University of Turku (Finland)
• ESR12: Computational methods for characterising T cell-related signatures in health and disease
(Laboratory of Laura Elo)

INSERM (Paris, France)
• ESR13: Characterisation of Tregs from inflamed tissues during autoimmunity
(Laboratory of Benoît Salomon)

Further details:
http://ec.europa.eu